Table 2 Chi-square test and Fisher’s exact test of relationship between DEK over expression and the clinicopathological features in colorectal cancers
From: DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
Characteristic | No. of cases | Strongly positive cases (%) | OR (95% CI) | P value |
|---|---|---|---|---|
Gender | Â | Â | 2.461 (0.924-6.556) | 0.067 |
 Male | 87 | 45 (51.72%) |  |  |
  Female | 22 | 8 (36.36%) |  |  |
Age (years old) | Â | Â | 1.298 (0.611-2.756) | 0.497 |
  ≥49 | 53 | 24 (45.28%) |  |  |
  <49 | 56 | 29 (51.79%) |  |  |
Tumor size (cm) | Â | Â | 2.353 (1.086-5.101) | 0.029 |
  ≤5 | 61 | 24 (39.34%) |  |  |
  >5 | 48 | 29 (60.42%) |  |  |
Location | Â | Â | 0.900 (0.424-1.910) | 0.784 |
  Colonic & ileocecal | 57 | 27 (47.37%) |  |  |
  Rectal | 52 | 26 (50.00%) |  |  |
Differentiation | Â | Â | 2.824 (1.291-6.177) | 0.009 |
  Well diff. | 49 | 17 (34.69%) |  |  |
  Poorly & mod. diff. | 60 | 36 (60.00%) |  |  |
Lymph node metastasis | Â | Â | 2.975 (1.360-6.509) | 0.006 |
  - | 60 | 22 (36.67%) |  |  |
  + | 49 | 31 (63.27%) |  |  |
Serosal invasion | Â | Â | 2.353 (1.072-5.163) | 0.031 |
  - | 57 | 17 (29.82%) |  |  |
  + | 52 | 26 (50.00%) |  |  |
Stage | Â | Â | 2.744 (1.261-5.971) | 0.010 |
  I-IIA | 59 | 22 (37.29%) |  |  |
  IIB-IIIC | 50 | 31 (62.00%) |  |  |
CEA | Â | Â | 0.610 (0.273-1.362) | 0.228 |
  Normal | 37 | 15 (40.54%) |  |  |
  Increased | 72 | 38 (52.78%) |  |  |